Literature DB >> 1627412

The radiological assessment of vertebral osteoporosis.

S Adami1, D Gatti, M Rossini, A Adamoli, G James, S Girardello, N Zamberlan.   

Abstract

The traditional skeletal X-ray is of little help in quantifying osteopenia in the spine, and indirect criteria, such as increased lucency, loss of horizontal trabeculae and reduction in end-plate thickness with relatively increased opaqueness, can be misleading. However, the clinical expression of osteoporosis is fracture, which can be identified by radiography. Any reduction in the anterior, middle, or total height of the vertebral body should be classified as vertebral fracture. In mild cases, such fractures are not easily detectable, particularly when previous radiographs are not available for comparison. Thus several objective methods for fracture identification have been developed. Most of these methods are based on the ratio between posterior and anterior or middle height (wedge or biconcave deformity, respectively) and on the ratio between posterior height of adjacent vertebrae or with a single vertebral reference (T4). Some of these indices are referred to normal ranges in order to take into account intervertebral and interindividual variability. In 36 women with postmenopausal osteoporosis we have compared the lateral radiographs of lumbar and thoracic spine to similar X-ray pictures taken by chance at least five years before menopause. By defining a fracture as any decrease in vertical height above 1 mm, we found 77 deforming events in 29 out of 36 patients. We then applied some of the methods to identify objectively fractures in our postmenopausal radiographs: the sensitivity of the various systems ranged from 50 to 100%; however there was a large overlap between false positives and false negatives and the methods with the highest sensitivity lack specificity and vice versa.

Entities:  

Mesh:

Year:  1992        PMID: 1627412     DOI: 10.1016/8756-3282(92)90194-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures.

Authors:  Neil Binkley; D Krueger; R Gangnon; H K Genant; M K Drezner
Journal:  Osteoporos Int       Date:  2005-04-15       Impact factor: 4.507

2.  Intra- and interobserver variability of Kleerekoper's method in vertebral fracture assessment.

Authors:  Nese Olmez; Taciser Kaya; Rezzan Gunaydin; Berna Dirim Vidinli; Nezahat Erdogan; Asuman Memis
Journal:  Clin Rheumatol       Date:  2004-11-18       Impact factor: 2.980

3.  Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures.

Authors:  C Y Wu; J Li; M Jergas; H K Genant
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

4.  Prevalence and treatment of fragility fractures in Spanish primary care: PREFRAOS study.

Authors:  Daniel Martínez-Laguna; Cristina Carbonell; José-Carlos Bastida; Milagros González; Rafael M Micó-Pérez; Francisco Vargas; Mónica Balcells-Oliver; Laura Canals
Journal:  Arch Osteoporos       Date:  2022-07-15       Impact factor: 2.879

Review 5.  Assessment of prevalent and incident vertebral fractures in osteoporosis research.

Authors:  H K Genant; M Jergas
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

6.  Appendicular cortical bone loss after age 65: sex-dependent event?

Authors:  D Maggio; R Pacifici; A Cherubini; M C Aisa; C Santucci; D Cucinotta; U Senin
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

7.  Vertebral compression fractures: a review of current management and multimodal therapy.

Authors:  Cyrus C Wong; Matthew J McGirt
Journal:  J Multidiscip Healthc       Date:  2013-06-17

8.  Standardised quantitative morphometry: a modified approach for quantitative identification of prevalent vertebral deformities.

Authors:  G Jiang; L Ferrar; N A Barrington; R Eastell
Journal:  Osteoporos Int       Date:  2007-05-26       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.